LabCorp adds Bionomics epilepsy tests to offerings
This article was originally published in Clinica
Laboratory Corporation of America (LabCorp) has expanded its diagnostic services to include epilepsy tests aimed at infants and young children, following a licensing agreement with Australian company Bionomics.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.